LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 1616-1624

  Graf, Beth ^a   Bushnell, Timothy ^a   Miller, Jim ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHOSPHATASE; TALIN; HLA ANTIGEN CLASS 2; IMMUNOLOGICAL ADJUVANT; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANTIGEN FUNCTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ADHESION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ISOLATION; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYNAPSE; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL COMMUNICATION; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL LINE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD45; CELL COMMUNICATION; CELL LINE, TUMOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TALIN; UP-REGULATION;

EID: 34548650329     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.1616     Document Type: Article

References (92)

1. Dustin, M. L., T. G. Bivona, and M. R. Philips. 2004. Membranes as messengers in T cell adhesion signaling. Nat. Immunol. 5: 363-372.
2. 2. J. Cell Biol. 167: 1241-1253.
3. Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5: 546-559.
4. Luo, B. H., and T. A. Springer. 2006. Integrin structures and conformational signaling. Curr. Opin. Cell Biol. 18: 579-586.
5. Cairo, C. W., R. Mirchev, and D. E. Golan. 2006. Cytoskeletal regulation couples LFA-1 conformational changes to receptor lateral mobility and clustering. Immunity 25: 297-308.
6. Semmrich, M., A. Smith, C. Feterowski, S. Beer, B. Engelhardt, D. H. Busch, B. Bartsch, M. Laschinger, N. Hogg, K. Pfeffer, and B. Holzmann. 2005. Importance of integrin LFA-1 deactivation for the generation of immune responses. J. Exp. Med. 201: 1987-1998.
7. Van Seventer, G., W. Newman, Y. Shimizu, T. Nutman, Y. Tanaka, K. Horgan, T. Gopal, E. Ennis, D. O'Sullivan, H. Grey, and S. Shaw. 1991. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J. Exp. Med. 174: 901-913.
8. Kuhlman, P., V. Moy, B. Lollo, and A. Brian. 1991. The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation: contributions of adhesion and co-activation. J. Immunol. 146: 1773-1782.
9. + T cells. Proc. Natl. Acad. Sci. USA 93: 14736-14741.
10. Bachmann, M., K. McKall-Faienza, R. Schmits, D. Bouchard, J. Beach, D. Speiser, T. Mak, and P. Ohashi. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7: 549-557.
11. Abraham, C., J. Griffith, and J. Miller. 1999. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J. Immunol. 162: 4399-4405.
12. + T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J. Immunol. 163: 4826-4832.
13. + T cell activation but both are required for optimal response. J. Immunol. 155: 45-57.
14. Zuckerman, L., L. Pullen, and J. Miller. 1998. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160: 3259-3268.
15. + T cells are poorly stimulated by ICAM-1. Eur. J. Immunol. 29: 45-53.
16. Gaglia, J. L., E. A. Greenfield, A. Mattoo, A. H. Sharpe, G. J. Freeman, and V. K. Kuchroo. 2000. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. J. Immunol. 165: 6091-6098.
17. Abraham, C., and J. Miller. 2001. Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J. Immunol. 167: 5193-5201.
18. Chirathaworn, C., J. E. Kohlmeier, S. A. Tibbetts, L. M. Rumsey, M. A. Chan, and S. H. Benedict. 2002. Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J. Immunol. 168: 5530-5537.
19. + T cells is required for optimal antigen-dependent activation in vivo. J. Immunol. 173: 4443-4451.
20. + T cells. J. Exp. Med. 180: 2125-2135.
21. Salomon, B., and J. Bluestone. 1998. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161: 5138-5142.
22. Luksch, C., O. Winqvist, M. Ozaki, L. Karlsson, M. Jackson, P. Peterson, and S. Webb. 1999. Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. Proc. Natl. Acad. Sci. USA 96: 3023-3028.
23. Jenks, S., and J. Miller. 2000. Inhibition of IL-4 responses after T cell priming in the context of LFA-1 costimulation is not reversed by restimulation in the presence of CD28 costimulation. J. Immunol. 164: 72-78.
24. Camacho, S. A., W. R. Heath, F. R. Carbone, N. Sarvetnick, A. LeBon, L. Karlsson, P. A. Peterson, and S. R. Webb. 2001. A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat. Immunol. 2: 523-529.
25. Smits, H. H., E. C. de Jong, J. H. Schuitemaker, T. B. Geijtenbeek, Y. van Kooyk, M. L. Kapsenberg, and E. A. Wierenga. 2002. Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J. Immunol. 168: 1710-1716.
26. Jenks, S. A., B. J. Eisfelder, and J. Miller. 2005. LFA-1 co-stimulation inhibits Th2 differentiation by down-modulating IL-4 responsiveness. Int. Immunol. 17: 315-323.
27. 2+ levels. J. Immunol. 149: 3872-3880.
28. Kanner, S., L. Grosmaire, J. Ledbetter, and N. Damle. 1993. -2-integrin LFA-1 signaling through phospholipase C-γ1 activation. Proc. Natl. Acad. Sci. USA 90: 7099-7103.
29. Wulfing, C., M. Sjaastad, and M. Davis. 1998. Visualizing the dynamics of T cell activation: ICAM-1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl. Acad. Sci. USA 95: 6302-6307.
30. + T cell proliferation requires phosphatidylinositol 3-kinase activity. J. Immunol. 166: 6523-6529.
31. Rodriguez-Fernandez, J. L., M. Gomez, A. Luque, N. Hogg, F. Sanchez-Madrid, and C. Cabanas. 1999. The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes. Mol. Biol. Cell 10: 1891-1907.
32. Shibuya, K., J. Shirakawa, T. Kameyama, S. Honda, S. Tahara-Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya. 2003. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198: 1829-1839.
33. 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86: 233-242.
34. Perez, O. D., D. Mitchell, G. C. Jager, S. South, C. Murriel, J. McBride, L. A. Herzenberg, S. Kinoshita, and G. P. Nolan. 2003. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat. Immunol. 4: 1083-1092.
35. Bianchi, E., S. Denti, A. Granata, G. Bossi, J. Geginat, A. Villa, L. Rogge, and R. Pardi. 2000. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404: 617-621.
36. Huppa, J., and M. Davis. 2003. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3: 973-983.
37. Friedl, P., A. T. den Boer, and M. Gunzer. 2005. Tuning immune responses: diversity and adaptation of the immunological synapse. Nat. Rev. Immunol. 5: 532-545.
38. Cemerski, S., and A. Shaw. 2006. Immune synapses in T-cell activation. Curr. Opin. Immunol. 18: 298-304.
39. Saito, T., and T. Yokosuka. 2006. Immunological synapse and microclusters: the site for recognition and activation of T cells. Curr. Opin. Immunol. 18: 305-313.
40. Monks, C., B. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82-86.
41. Katagiri, K., A. Maeda, M. Shimonaka, and T. Kinashi. 2003. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4: 741-748.
42. Bromley, S., A. Iaboni, S. Davis, A. Whitty, J. Green, A. Shaw, A. Weiss, and M. Dustin. 2001. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2: 1159-1166.
43. Huang, J., P. Lo, T. Zal, N. Gascoigne, B. Smith, S. Levin, and H. Grey. 2002. CD28 plays a critical role in the segregation of PKCθ within the immunological synapse. Proc. Natl. Acad. Sci. USA 99: 9369-9373.
44. Sanchez-Lockhart, M., E. Marin, B. Graf, R. Abe, Y. Harada, C. E. Sedwick, and J. Miller. 2004. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J. Immunol. 173: 7120-7124.
45. Stinchcombe, J., G. Bossi, S. Booth, and G. Griffiths. 2001. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15: 751-761.
46. Sperling, A. I., J. R. Sedy, N. Manjunath, A. Kupfer, B. Ardman, and J. K. Burkhardt. 1998. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J. Immunol. 161: 6459-6462.
47. Allenspach, E., P. Cullinan, J. Tong, Q. Tang, A. Tesciuba, J. Cannon, S. Takahashi, R. Morgan, J. Burkhardt, and A. Sperling. 2001. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 15: 739-750.
48. Delon, J., K. Kaibuchi, and R. Germain. 2001. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 15: 691-701.
49. Johnson, K., S. Bromley, M. Dustin, and M. Thomas. 2000. A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc. Natl. Acad. Sci. USA 97: 10138-10143.
50. Freiberg, B., H. Kupfer, W. Maslanik, J. Delli, J. Kapplar, D. Zaller, and A. Kupfer. 2002. Staging and resetting T cell activation in SMACs. Nat. Immunol. 3: 911-917.
51. Lee, K.-H., A. Dinner, C. Tu, G. Campi, S. Raychaudhuri, R. Varma, T. Sims, W. Burack, H. Wu, J. Wang, et al. 2003. The immunological synapse balances T cell receptor signaling and degredation. Science 302: 1218-1222.
52. Campi, G., R. Varma, and M. L. Dustin. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202: 1031-1036.
53. Yokosuka, T., K. Sakata-Sogawa, W. Kobayashi, M. Hiroshima, A. Hashimoto-Tane, M. Tokunaga, M. L. Dustin, and T. Saito. 2005. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. 6: 1253-1262.
54. Varma, R., G. Campi, T. Yokosuka, T. Saito, and M. L. Dustin. 2006. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25: 117-127.
55. Sedwick, C., L. Jusino, J. Cannon, M. Morgan, J. Miller, and J. Burkhardt. 1999. TCR, LFA-1 and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162: 1367-1375.
56. Scharffetter-Kochanek, K., H. Lu, K. Norman, N. van Nood, F. Munoz, S. Grabbe, M. McArthur, I. Lorenzo, S. Kaplan, K. Ley, et al. 1998. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. Exp. Med. 188: 119-131.
57. Anderson, M., K. Swier, L. Arneson, and J. Miller. 1993. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178: 1959-1969.
58. Grakoui, A., S. Bromley, C. Sumen, M. Davis, A. Shaw, P. Allen, and M. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
59. Krummel, M., and M. Davis. 2002. Dynamics of the immunological synapse: finding, establishing, and solidifying a connection. Curr. Opin. Immunol. 14: 66-74.
60. Wulfing, C., and M. Davis. 1998. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282: 2266-2269.
61. Wulfing, C., C. Sumen, M. Sjaastad, L. Wu, M. Dustin, and M. Davis. 2002. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat. Immunol. 3: 42-47.
62. Wetzel, S. A., T. W. McKeithan, and D. C. Parker. 2002. Live-cell dynamics and the role of costimulation in immunological synapse formation. J. Immunol. 169: 6092-6101.
63. Purtic, B., L. A. Pitcher, N. S. van Oers, and C. Wulfing. 2005. T cell receptor (TCR) clustering in the immunological synapse integrates TCR and costimulatory signaling in selected T cells. Proc. Natl. Acad. Sci. USA 102: 2904-2909.
64. Irvine, D., M. Purbhoo, M. Krogsgaard, and M. Davis. 2002. Direct observation of ligand recognition by T cells. Nature 419: 845-849.
65. Sumen, C., M. L. Dustin, and M. M. Davis. 2004. T cell receptor antagonism interferes with MHC clustering and integrin patterning during immunological synapse formation. J. Cell Biol. 166: 579-590.
66. Hermiston, M. L., Z. Xu, and A. Weiss. 2003. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21: 107-137.
67. Negulescu, P., T. Krasieva, A. Khan, H. Kerschbaum, and M. Cahalan. 1996. Polarity of T cell shape, motility, and sensitivity to antigen. Immunity 4: 421-430.
68. Sanchez-Lockhart, M., and J. Miller. 2006. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability, but not IL-2 transcription. J. Immunol. 176: 4778-4784.
69. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kapplar. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8: 675-682.
70. Huppa, J., M. Gleimer, C. Sumen, and M. Davis. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4: 749-755.
71. Van der Merwe, P., and A. Barclay. 1994. Transient intercellular adhesion: the importance of weak protein:protein interactions. Trends Biol. Sci. 19: 354-358.
72. Shaw, A., and M. Dustin. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6: 361-369.
73. Wild, M., A. Cambiaggi, M. Brown, E. Davies, H. Ohno, T. Saito, and P. van der Merwe. 1999. Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex. J. Exp. Med. 190: 31-41.
74. Choudhuri, K., D. Wiseman, M. H. Brown, K. Gould, and P. A. van der Merwe. 2005. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 436: 578-582.
75. Iida, N., V. B. Lokeshwar, and L. Y. Bourguignon. 1994. Mapping the fodrin binding domain in CD45, a leukocyte membrane-associated tyrosine phosphatase. J. Biol. Chem. 269: 28576-28583.
76. Wu, L., J. Fu, and S. H. Shen. 2002. SKAP55 coupled with CD45 positively regulates T-cell receptor-mediated gene transcription. Mol. Cell. Biol. 22: 2673-2686.
77. Anderson, M. E., and T. J. Siahaan. 2003. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides 24: 487-501.
78. Shimaoka, M., and T. A. Springer. 2003. Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov. 2: 703-716.
79. Nicolls, M. R., M. Coulombe, H. Yang, A. Bolwerk, and R. G. Gill. 2000. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-γ or IL-4. J. Immunol. 164: 3627-3634.
80. Bertry-Coussot, L., B. Lucas, C. Danel, L. Halbwachs-Mecarelli, J. F. Bach, L. Chatenoud, and P. Lemarchand. 2002. Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway. J. Immunol. 168: 3641-3648.
81. Nicolls, M. R., M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill. 2002. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol. 169: 4831-4839.
82. Schmits, R., T. Kündig, D. Baker, G. Shumaker, J. Simard, G. Duncan, A. Wakeham, A. Shahinian, A. van der Heiden, M. Bachmann, et al. 1996. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183: 1415-1426.
83. Shier, P., G. Otulakowski, K. Ngo, J. Panakos, E. Chourmouzis, L. Christjansen, C. Lau, and W. Fung-Leung. 1996. Impaired immune response toward alloantigens and tumor cells but normal thymic selection in mice deficient in the β2 leukocyte function associated antigen-1. J. Immunol. 157: 5375-5386.
84. Martin, S. 2001. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J. Autoimmun. 17: 109-117.
85. Emoto, M., M. Miyamoto, Y. Emoto, I. Yoshizawa, V. Brinkmann, N. van Rooijen, and S. H. Kaufmann. 2003. Highly biased type 1 immune responses in mice deficient in LFA-1 in Listeria monocytogenes infection are caused by elevated IL-12 production by granulocytes. J. Immunol. 171: 3970-3976.
86. Miyamoto, M., M. Emoto, Y. Emoto, V. Brinkmann, I. Yoshizawa, P. Seiler, P. Aichele, E. Kita, and S. H. Kaufmann. 2003. Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: possible contribution of granulocyte-colony-stimulating factor and IL-17. J. Immunol. 170: 5228-5234.
87. Emoto, M., Y. Emoto, V. Brinkmann, M. Miyamoto, I. Yoshizawa, M. Staber, N. van Rooijen, A. Hamann, and S. H. Kaufmann. 2003. Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-α and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance. J. Immunol. 171: 584-593.
88. Berlin-Rufenach, C., F. Otto, M. Mathies, J. Westermann, M. J. Owen, A. Hamann, and N. Hogg. 1999. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J. Exp. Med. 189: 1467-1478.
89. Ding, Z. M., J. E. Babensee, S. I. Simon, H. Lu, J. L. Perrard, D. C. Bullard, X. Y. Dai, S. K. Bromley, M. L. Dustin, M. L. Entman, et al. 1999. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J. Immunol. 163: 5029-5038.
90. 2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J. Clin. Invest. 109: 183-192.
91. Lee, S. H., J. E. Prince, M. Rais, F. Kheradmand, F. Shardonofsky, H. Lu, A. L. Beaudet, C. W. Smith, L. Soong, and D. B. Corry. 2003. Differential requirement for CD18 in T-helper effector homing. Nat. Med. 9: 1281-1286.
92. Zhang, Q. W., D. D. Kish, and R. L. Fairchild. 2003. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection. J. Immunol. 170: 5530-5537.